We assessed the bone status of preterm and term infants by measuring their bone mineral density (BMD) by dual-energy X-ray absorptiometry (DXA). Thirty neonates weighing 699-3590 g were selected as subjects. Infants with multiple anomalies or severe chronic lung disease were excluded. Using the corrected term age (35-48 weeks), we measured their lumbar spinal BMD (L1-L4) by DXA. Alkaline phosphatase (ALP) and skeletal alkaline phosphatase (B-ALP) were measured at the same time. In addition, we compared the BMD values with growth parameters and chemical markers. The term BMD correlated significantly with the birth weight (r ϭ .90), height (r ϭ .85), and gestational age (r ϭ .76). The birth weight correlated more closely with the BMD than with the weight at the time of BMD measurement. The B-ALP level showed an inverse correlation with BMD (r ϭ Ϫ0.41). The preterm infants apparently acquired lower BMDs during intrauterine life. The inverse correlation of B-ALP with BMD may be found only in the neonatal period. The BMD measured by DXA and the B-ALP level are very useful parameters for assessing bone status in infants, including extremely low birth weight infants.
Introduction
Preterm infants have a high risk of developing a bone growth disturbance such as rickets or osteopenia [1] [2] [3] [4] . For assessment of bone status, several studies have used single-photon absorptiometry to determine the bone mineral density (BMD) of the appendicular skeletal bones such as the radius, ulna, and humerus, which are largely composed of cortical bone [5] [6] [7] [8] . Bernard et al.
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Received: Aug. 21, 1997 / Accepted: Nov. 6, 1997 stated that the precision of single photon absorptiometry was weak because of the activity of the radioactive source (T for 125 I ϭ 60 days), the reportioning of the bone, and the surrounding soft tissue thickness, which should be constant, although the precision is improving [9] . Dual-energy X-ray absorptiometry (DXA) is useful for assessing whole-body and regional bone, as well as fat and fat-free, mineral-free soft tissue masses [10] . DXA has recently been used as a rapid and noninvasive method to analyze bone status in children and infants [11] [12] [13] [14] [15] [16] [17] . Several studies have measured the BMD of preterm infants [9, [18] [19] [20] [21] [22] [23] [24] .
Serum alkaline phosphatase (ALP) and skeletal alkaline phosphatase (B-ALP) have been reported to be useful markers of metabolic bone disease in preterm infants [25] [26] [27] . Only BMD data show the static bone status. Additional ALP and B-ALP data analyses may show bone status, including bone turnover dynamics. In the present study, therefore, we examined the correlations between BMD and B-ALP and between BMD and ALP in preterm infants. B-ALP is a marker of bone formation and therefore correlates positively with BMD values in normal subjects, but in the neonatal period, a special bone formation period, the correlation between B-ALP and BMD values has not been established.
Methods

Subjects
Between May 1995 and February 1996, 225 infants were admitted to the Yodogawa Christian Hospital neonate intensive care unit (NICU), Osaka, Japan. Of these infants, 15 weighed Ϲ999 g; 20, 1000-1499 g; 94, 1500-2499 g; and 96, м2500 g). Of these, we identified 30 relatively stable infants; their ranges of gestational age, birth weight, and birth height were 26-41 weeks (average, 33.0 weeks), 699-3590 g (average, 1752 g), and 29.0-52.0 cm (average, 40.2 cm), respectively. Infants with multiple anomalies, severe chronic lung disease, or prolonged poor nutrition (lasting more than 2 weeks) were excluded from the study. Intravenous hyperalimentation was not administered to any of the study infants. The personal data of the infants are shown in Table 1 . Informed consent for the study was obtained from their parents. Approval was obtained from the ethical committee of the hospital for the study. Four infants whose weights were low for their gestational age were included. The weights of the remaining 26 infants were appropriate for their gestational age. Seven infants had extremely low birth weights (Ϲ999 g), 5 had very low birth weights (1000-1499 g), 13 had low birth weights (1500-2499 g), and 5 had normal birth weights (м2500 g).
Feeding regimen
The infants were fed mainly with breast milk. If breast milk was not sufficient, formula milk (Neomilk P-ai; Yukijirushi, Tokyo, Japan) or special premature formula milk (PM, Yukijirushi) was given as a supplement. For the infants with very low or extremely low birth weights, calcium gluconate was administered intravenously or orally (300-500 mg/kg per day) to maintain the serum calcium level within 8.7-10.1 mg/dl. For the breastfed infants, 50 mg of phosphorus (as 0.5 mmol of dibasic potassium phosphate) was added to 100 ml of breast milk when the serum phosphorus level was less than 5.0 mg/dl. If the serum ALP level was more than 30 King-Armstrong unit [KAU], the infant was administered 1-α-D 3 (alfacacidol, 0.05-0.1 µg/kg per day). If the urinary calcium creatinine ratio was greater than 0.5, the alfacacidol was withdrawn.
BMD measurement
The BMD was measured around the corrected term age (35-45 weeks). The spinal BMD in the L1-L4 region was measured with the infant in the supine position with a commercially available DXA unit (Hologic QDR-2000; Hologic, Waltham, MA, USA). All infants were sedated with sodium triclofos (0.5-1.0 mg/kg) before the 10% of the exposure for a standard chest X-ray [14, 23, 24] .
Biochemical markers
The biochemical markers of serum calcium, phosphorus, ALP, and B-ALP were measured in the study infants. DXA. A special program for small bone measurements is available from the DXA manufacturer, but the time necessary to scan the lumbar spine (8-10 min) was too long for the babies to remain still during the procedure. For this study, we used an "ultrahigh resolution" (UHR) version of the standard program for lumbar spine scanning in adults [13] . Although this protocol did not alter the image resolution, it used a lower thresh-old detection and therefore correctly identified bone edges, which appeared as dotted lines surrounding the vertebrae. Another advantage is the short scanning time (lumbar spine, 2-3 min). The irradiation dose was approximately 3 mrem, which is about with the BMD (r ϭ Ϫ.41, P Ͻ .02), but that of ALP did not (r ϭ Ϫ.26, P: ns).
Discussion
Neonatal rickets and osteopenia are occasionally seen in preterm infants and are often associated with prolonged poor nutrition or chronic lung disease. Rickets and osteopenia are considered to have the same etiology [1] [2] [3] [4] . These two diseases in preterm infants have recently been termed "metabolic bone disease in preterm infants" [1, 31] . A nutritional deficiency involving vitamin D, calcium, and phosphorus is considered to be the cause. These diseases were previously considered to the induced by a deficiency of vitamin D only [32] [33] [34] [35] . Recently, however, hypocalcemia or hypophosphatemia have also been postulated as causes, although the serum calcium and phosphorus levels are variable in infants with these diseases [1, 19, 31, [36] [37] [38] [39] [40] [41] [42] [43] . The diseases may thus be induced by a combination of causes. Several methods have been proposed to assess bone diseases, including the measurement of serum ALP, but serum ALP is not always elevated in infants with a bone disease. Radial X-rays can be a useful technique for detecting metabolic bone diseases [1] [2] [3] [4] , but this method is not quantitative. Therefore, new methods are necessary to determine the bone status of preterm infants.
Glastre et al. observed that BMD correlated well with the growth parameters of body surface area, height, and weight in a study of small children. These parameters showed greater correlations with BMD than did age [44] . Our results showed that birth weight and height were more highly correlated with BMD using the gestational age than the corrected term age, despite the inclusion of four infants whose weight was low for their 
Statistical analyses
The data were analyzed by regression correlative line, coefficients, and Student's t-test. P values less than .05 were considered significant. Figure 1 shows the correlation between BMD and the corrected age for gestation at the time of BMD measurement as well as the gestational age at birth. The correlation coefficients of BMD at the measurement and the gestational age were Ϫ.035 and .76, respectively (P: ns and P Ͻ .001). The gestational age at birth showed a greater correlation with the BMD than did the corrected age for gestation at the BMD measurement. Figure 2 shows the correlation of BMD with body weight at the time of the BMD measurement and with birth weight. Both weights were significantly correlated with the BMD. The correlation coefficients of BMD with the body weight at the BMD measurement and birth weight were .55 (P Ͻ .001) and .90 (P Ͻ .001), respectively. The birth weight showed a greater correlation with BMD than did the body weight at BMD measurement. Figure 3 shows the correlation of the BMD with height at the BMD measurement and birth height. Both heights were significantly correlated with the BMD; the coefficients were .53 (term height, P Ͻ .01) and .85 (birth height, P Ͻ .001), respectively. The birth height showed a greater correlation with BMD than did the height at BMD measurement. Of these factors, birth weight showed the greatest correlation with BMD. Figure 4 shows the correlation of the BMD with the ALP and B-ALP levels around the corrected term age. The level of B-ALP showed a significant correlation gestational age. Therefore, the BMD around the corrected term age may be estimated by birth weight and birth height in preterm infants. The BMD data of the four low-for-gestational-age infants also agreed with the data of appropriate-for-gestational age, and thus the influence of bone developmental delay of the low-forgestational-age infants can be excluded.
Results
The infants in our study, including 12 extremely or very low birth weight infants, had a relative stable course without serious complications such as prolonged poor nutrition or chronic lung disease. Nutritional supplements were also relatively well tolerated. Clinical rickets was not apparent in the study infants. Despite receiving these nutritional supplement treatments, low BMD was observed on DXA in the preterm infants compared to the term infants. Birth weight and height showed greater correlations with BMD than did the weight and height around the corrected term age when the BMD was measured. Therefore, the preterm infants apparently did not obtain sufficient BMD during intrauterine life. A new postnatal nutritional strategy may be necessary to promote bone mineral nutrition, and further study is needed to determine the timepoint at which preterm infants catch up with term infants with regard to BMD.
ALP is used as a marker for bone status or metabolic bone disease in preterm infants. A modified B-ALP measuring method has been recently developed [25] [26] [27] . B-ALP is specific to bone metabolism, and most B-ALP originates from osteoblasts. During ossification, the B-ALP activity significantly increases, and the change is parallel to bone formation. Because the B-ALP level in infants with rickets is increased, there is a close correlation between the B-ALP level and the severity of rickets [1] . Our current data showed that B-ALP had an inverse correlation with the BMD, and we speculate that this relationship exists because preterm infants may not have sufficient BMD at their birth and their term age. Their bone turnover may be activated to compensate for insufficient BMD, and it may continue through their term age, with the same etiology as that of rickets. Therefore, despite the low BMD, bone formation markers might be elevated, only in the neonatal period, and especially in preterm infants. The BMD data of all the study infants are by corrected term age, thus excluding the influence of the rapid developmental stage of 34-35 weeks of gestation. Our results showed that an insufficient nutritional supplementation for preterm infants may cause active bone formation, and their bone formation system may be kept intact in the special neonatal period. In short, prematurity may cause the same bone status as rickets, regardless of the absence of apparent clinical rickets.
In conclusion, preterm infants exhibited low BMD. DXA is a very useful method for measuring the BMD and assessing bone status in infants, including that in extremely low birth weight infants. Further study on BMD may contribute to the development of better nutritional support for low birth weight infants, including extremely low birth weight infants. 
